Worth Venture Partners’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Worth Venture Partners’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-101,364	Closed	-$203K	–	118
2019 Q3	$203K	Buy	101,364 +14,107	+16%	+$28.6K	0.12%	70
2019 Q2	$249K	Sell	87,257 -84,809	-49%	-$217K	0.14%	63
2019 Q1	$544K	Buy	+172,066	New	+$557K	0.3%	45
2018 Q4	–	Sell	-43,000	Closed	-$173K	–	184
2018 Q3	$173K	Buy	+43,000	New	+$190K	0.13%	75

Other funds holding CORV

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Worth Venture Partners's CORV Position: Q4 2019 in Review

Worth Venture Partners sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2019, closing a stake of 101,364 shares — an estimated $203K sold.

Worth Venture Partners first reported a position in CORV in Q3 2018 and held it in 4 quarters. The position peaked at $544K in Q1 2019. 31 funds tracked by Wall St. Rank hold CORV as of Q4 2019.

Worth Venture Partners reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2019 after selling out during the quarter.
Worth Venture Partners sold 101,364 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2019, an estimated $203K.
Worth Venture Partners first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2018 and held it in 4 quarters.
Worth Venture Partners's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $544K in Q1 2019.
31 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2019.

Based on Worth Venture Partners's 13F filing for Q4 2019, filed 14 Feb 2020.